These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 28791306)
1. Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems. Granja A; Frias I; Neves AR; Pinheiro M; Reis S Biomed Res Int; 2017; 2017():5813793. PubMed ID: 28791306 [TBL] [Abstract][Full Text] [Related]
2. Design, development, and characterization of lipid nanocarriers-based epigallocatechin gallate delivery system for preventive and therapeutic supplementation. Frias I; Neves AR; Pinheiro M; Reis S Drug Des Devel Ther; 2016; 10():3519-3528. PubMed ID: 27826184 [TBL] [Abstract][Full Text] [Related]
3. Nanochemoprevention with therapeutic benefits: An updated review focused on epigallocatechin gallate delivery. Yang QQ; Wei XL; Fang YP; Gan RY; Wang M; Ge YY; Zhang D; Cheng LZ; Corke H Crit Rev Food Sci Nutr; 2020; 60(8):1243-1264. PubMed ID: 30799648 [TBL] [Abstract][Full Text] [Related]
4. Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy. Granja A; Pinheiro M; Reis S Nutrients; 2016 May; 8(5):. PubMed ID: 27213442 [TBL] [Abstract][Full Text] [Related]
5. Stability of (-)-epigallocatechin gallate and its activity in liquid formulations and delivery systems. Krupkova O; Ferguson SJ; Wuertz-Kozak K J Nutr Biochem; 2016 Nov; 37():1-12. PubMed ID: 27770867 [TBL] [Abstract][Full Text] [Related]
6. Chitosan nanoparticles enhance the plasma exposure of (-)-epigallocatechin gallate in mice through an enhancement in intestinal stability. Dube A; Nicolazzo JA; Larson I Eur J Pharm Sci; 2011 Oct; 44(3):422-6. PubMed ID: 21925598 [TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin-3-gallate at the nanoscale: a new strategy for cancer treatment. Sun W; Yang Y; Wang C; Liu M; Wang J; Qiao S; Jiang P; Sun C; Jiang S Pharm Biol; 2024 Dec; 62(1):676-690. PubMed ID: 39345207 [TBL] [Abstract][Full Text] [Related]
8. Improving the effectiveness of (-)-epigallocatechin gallate (EGCG) against rabbit atherosclerosis by EGCG-loaded nanoparticles prepared from chitosan and polyaspartic acid. Hong Z; Xu Y; Yin JF; Jin J; Jiang Y; Du Q J Agric Food Chem; 2014 Dec; 62(52):12603-9. PubMed ID: 25483592 [TBL] [Abstract][Full Text] [Related]
9. Encapsulation of biophenolic phytochemical EGCG within lipid nanoparticles enhances its stability and cytotoxicity against cancer. Radhakrishnan R; Kulhari H; Pooja D; Gudem S; Bhargava S; Shukla R; Sistla R Chem Phys Lipids; 2016 Jun; 198():51-60. PubMed ID: 27234272 [TBL] [Abstract][Full Text] [Related]
10. (-)-Epigallocatechin gallate (EGCG)-nanoethosomes as a transdermal delivery system for docetaxel to treat implanted human melanoma cell tumors in mice. Liao B; Ying H; Yu C; Fan Z; Zhang W; Shi J; Ying H; Ravichandran N; Xu Y; Yin J; Jiang Y; Du Q Int J Pharm; 2016 Oct; 512(1):22-31. PubMed ID: 27544847 [TBL] [Abstract][Full Text] [Related]
11. Cancer therapeutics with epigallocatechin-3-gallate encapsulated in biopolymeric nanoparticles. Tyagi N; De R; Begun J; Popat A Int J Pharm; 2017 Feb; 518(1-2):220-227. PubMed ID: 27988378 [TBL] [Abstract][Full Text] [Related]
12. Nanochemoprevention by encapsulation of (-)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability. Hu B; Ting Y; Yang X; Tang W; Zeng X; Huang Q Chem Commun (Camb); 2012 Feb; 48(18):2421-3. PubMed ID: 22266839 [TBL] [Abstract][Full Text] [Related]
13. Tumor-Homing Cell-Penetrating Peptide Linked to Colloidal Mesoporous Silica Encapsulated (-)-Epigallocatechin-3-gallate as Drug Delivery System for Breast Cancer Therapy in Vivo. Ding J; Yao J; Xue J; Li R; Bao B; Jiang L; Zhu JJ; He Z ACS Appl Mater Interfaces; 2015 Aug; 7(32):18145-55. PubMed ID: 26225796 [TBL] [Abstract][Full Text] [Related]
17. Improved anticancer effects of epigallocatechin gallate using RGD-containing nanostructured lipid carriers. Hajipour H; Hamishehkar H; Nazari Soltan Ahmad S; Barghi S; Maroufi NF; Taheri RA Artif Cells Nanomed Biotechnol; 2018; 46(sup1):283-292. PubMed ID: 29310467 [TBL] [Abstract][Full Text] [Related]
18. Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (-)-epigallocatechin gallate. Dube A; Nicolazzo JA; Larson I Eur J Pharm Sci; 2010 Oct; 41(2):219-25. PubMed ID: 20600878 [TBL] [Abstract][Full Text] [Related]
19. Fabrication of chitosan-coated epigallocatechin-3-gallate (EGCG)-hordein nanoparticles and their transcellular permeability in Caco-2/HT29 cocultures. Song H; He A; Guan X; Chen Z; Bao Y; Huang K Int J Biol Macromol; 2022 Jan; 196():144-150. PubMed ID: 34914913 [TBL] [Abstract][Full Text] [Related]
20. pH and temperature stability of (-)-epigallocatechin-3-gallate-β-cyclodextrin inclusion complex-loaded chitosan nanoparticles. Liu F; Majeed H; Antoniou J; Li Y; Ma Y; Yokoyama W; Ma J; Zhong F Carbohydr Polym; 2016 Sep; 149():340-7. PubMed ID: 27261758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]